[PHA-stimulation of blood lymphocytes in patients with multiple sclerosis during combined therapy with aldosterone and spirolactone derivatives].
D000450:Aldosterone / Q000494:pharmacology / Q000627:therapeutic use*; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D037102:Lectins; D008213:Lymphocyte Activation / Q000187:drug effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011868:Radioisotopes; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D013942:Thymine Nucleotides
D037102:Lectins; D011868:Radioisotopes; D013942:Thymine Nucleotides; D013148:Spironolactone; D000450:Aldosterone; D004247:DNA
Die PHA-Stimulierbarketi von Blutlymphocyten bei Patienten mit Multipler Sklerose unter einer kombinierten Therapie mit Aldosteron und Spirolactone-Derivaten.